|
US6635632B1
(en)
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
AU4710499A
(en)
*
|
1998-06-22 |
2000-01-10 |
Elan Pharmaceuticals, Inc. |
Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds
|
|
US6958330B1
(en)
|
1998-06-22 |
2005-10-25 |
Elan Pharmaceuticals, Inc. |
Polycyclic α-amino-ε-caprolactams and related compounds
|
|
WO1999067219A1
(en)
*
|
1998-06-22 |
1999-12-29 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
|
|
US6552013B1
(en)
|
1998-06-22 |
2003-04-22 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6774125B2
(en)
|
1998-06-22 |
2004-08-10 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
EP1089981A1
(en)
*
|
1998-06-22 |
2001-04-11 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis.
|
|
US6509331B1
(en)
|
1998-06-22 |
2003-01-21 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
HRP990246A2
(en)
|
1998-08-07 |
2000-06-30 |
Du Pont Pharm Co |
Succinoylamino benzodiazepines as inhibitors of a beta protein production
|
|
NZ525513A
(en)
|
1998-08-07 |
2004-09-24 |
Pont Pharmaceuticals Du |
Succinoylamino lactams as inhibitors of Abeta protein production
|
|
US6486350B1
(en)
|
1998-09-30 |
2002-11-26 |
Elan Pharmaceuticals Inc. |
Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide
|
|
EP1313426A2
(en)
|
1998-12-24 |
2003-05-28 |
Bristol-Myers Squibb Pharma Company |
Succinoylamino benzodiazepines as inhibitors of a-beta protein production
|
|
PL350050A1
(en)
|
1999-01-22 |
2002-10-21 |
Elan Pharm Inc |
Acyl derivatives which treat vla-4 related disorders
|
|
US6503902B2
(en)
|
1999-09-13 |
2003-01-07 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
|
|
US6960576B2
(en)
|
1999-09-13 |
2005-11-01 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
|
|
WO2001027108A1
(en)
|
1999-10-08 |
2001-04-19 |
Bristol-Myers Squibb Pharma Company |
AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
|
IL150374A0
(en)
|
1999-12-23 |
2002-12-01 |
Neurochem Inc |
Compounds and methods for modulating cerebral amyloid angiopathy
|
|
US6525044B2
(en)
|
2000-02-17 |
2003-02-25 |
Bristol-Myers Squibb Company |
Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production
|
|
CN1436175A
(zh)
|
2000-04-03 |
2003-08-13 |
布里斯托尔-迈尔斯斯奎布药品公司 |
作为Aβ－蛋白生产抑制剂的环状内酰胺
|
|
JP2004508289A
(ja)
|
2000-04-03 |
2004-03-18 |
デュポン ファーマシューティカルズ カンパニー |
Ａβタンパク質産生の阻害剤としての環状ラクタム
|
|
CA2404273A1
(en)
|
2000-04-11 |
2001-10-18 |
Bristol-Myers Squibb Pharma Company |
Substituted lactams as inhibitors of a.beta. protein production
|
|
US6878363B2
(en)
|
2000-05-17 |
2005-04-12 |
Bristol-Myers Squibb Pharma Company |
Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
|
|
EP1268450A1
(en)
|
2000-06-01 |
2003-01-02 |
Bristol-Myers Squibb Pharma Company |
Lactams substituted by cyclic succinates as inhibitors of a-beta protein production
|
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
|
CN100396680C
(zh)
*
|
2000-12-28 |
2008-06-25 |
第一制药株式会社 |
极迟抗原-4抑制剂
|
|
US7157487B2
(en)
*
|
2000-12-28 |
2007-01-02 |
Daiichi Pharmaceutical Co., Ltd. |
Vla-4 inhibitors
|
|
CA2469130A1
(en)
*
|
2001-12-04 |
2003-06-12 |
Elan Pharmaceuticals, Inc. |
Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
|
|
TWI281470B
(en)
|
2002-05-24 |
2007-05-21 |
Elan Pharm Inc |
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
|
|
TW200307671A
(en)
|
2002-05-24 |
2003-12-16 |
Elan Pharm Inc |
Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
|
|
US7459476B2
(en)
|
2002-06-27 |
2008-12-02 |
Elan Pharmaceuticals, Inc. |
Methods for treating Alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
|
|
FR2842523A1
(fr)
*
|
2002-07-17 |
2004-01-23 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
|
|
EP1650205B1
(en)
|
2003-07-24 |
2012-04-25 |
Daiichi Sankyo Company, Limited |
Cyclohexanecarboxylic acid compound
|
|
ATE493405T1
(de)
|
2005-09-29 |
2011-01-15 |
Elan Pharm Inc |
Pyrimidinylamidverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren
|
|
CA2624524C
(en)
|
2005-09-29 |
2014-07-08 |
Elan Pharmaceuticals, Inc. |
Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
WO2007101165A1
(en)
|
2006-02-27 |
2007-09-07 |
Elan Pharmaceuticals, Inc. |
Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
|